Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Davis Polk Advises Venus Medtech (Hangzhou) Inc. on Its HK$2.59 Billion (US$331.17 Million) Initial Public Offering
Davis Polk advised Venus Medtech (Hangzhou) Inc. in connection with its initial public offering and listing on the Hong Kong…
IVERIC bio, Inc. Common Stock and Pre-Funded Warrants Offering
Davis Polk advised the sole book-running manager and representative of the several underwriters in connection with a $45…
Ardelyx, Inc. $144 Million Follow-On Public Offering
Davis Polk advised the joint book-running managers for the public offering of common stock by Ardelyx, Inc for gross…
Millendo Therapeutics, Inc. $25 Million Offering of Common Shares
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with…
Kodiak Sciences Inc. $317 Million Follow-On Offering
Davis Polk advised the joint bookrunning managers and representatives of the several underwriters in connection with a $317…
Revance Therapeutics, Inc. $110 Million Common Stock Offering
Davis Polk advised the joint lead book-running managers and representatives of the several underwriters in connection…
AbbVie Inc. $30 Billion Senior Notes Offering
Davis Polk advised the initial purchasers in connection with an unregistered offering by AbbVie Inc. of $30 billion…
Davis Polk Advises Roche on Its Acquisition of Promedior
Davis Polk is advising Roche on its acquisition of Promedior, Inc. Under the terms of the merger agreement, Roche will make…
Davis Polk Advises Shockwave Medical, Inc. on Its $90 Million Public Offering
Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 2,481,781 shares of common stock for an…
Affimed N.V. $34.5 Million Offering of Common Shares
Davis Polk advised the underwriters in connection with the $34.5 million public offering of 13,800,000 common shares of…